Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease

Published:2020-04 Issue: Volume:305 Page:139-146
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Moroi Masao,Nagayama Daiji,Hara Fumihiko,Saiki Atsuhito,Shimizu Kazuhiro,Takahashi Mao,Sato Naoko,Shiba Teruo,Sugimoto Hideki,Fujioka Toshiki,Chiba Tatsuo,Nishizawa Kosuke,Usui Shuki,Iwasaki Yasuo,Tatsuno Ichiro,Sugi Kaoru,Yamasaki Junichi,Yamamura Shigeo,Shirai Kohji

Funder

Toho University

Bayer Yakuhin, Ltd

Sanofi KK

MSD KK

Novartis Pharma, Ltd

Teijin Pharma

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Co., Ltd.

Nihon Mediphysics, Ltd.

Mitsubishi Tanabe Pharma

Daiichi Sankyo Company, Limited

Ono Pharmaceutical Co., Ltd.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial;Nakamura;Lancet,2006

2. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial;Ridker;Lancet,2009

3. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study;Okazaki;Circulation,2004

4. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS);Takayama;Circ. J.,2009

5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid Microneedle-Mediated Transdermal Delivery of Atorvastatin Calcium-Loaded Polymeric Micelles for Hyperlipidemia Therapy;ACS Applied Bio Materials;2024-05-24

2. Pitavastatin: A Comprehensive Overview of its Mechanisms, Pharmacokinetics, Pharmacodynamics, and Adverse Effects;2024-02-23

3. Effect of atorvastatin calcium plus clopidogrel in the treatment of patients with transient ischemic attacks and its effect on blood lipids and platelets;International Journal of Neuroscience;2024-02-08

4. Antioxidant Activity via Free Radical Scavenging of Pitavastatin and Its Hydroxylated Derivatives: A Quantum Chemical Attempt Aiming to Assist Drug Development;Advanced Theory and Simulations;2024-01-02

5. Position Paper of the Polish Expert Group on the Use of Pitavastatin in the Treatment of Lipid Disorders in Poland Endorsed by the Polish Lipid Association.;Archives of Medical Science;2023-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3